about
The murine stanniocalcin 2 gene is a negative regulator of postnatal growthChallenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, miceLoss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humansDistinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissueNegative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanismCalpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair.Functional identity of the gamma tropomyosin gene: Implications for embryonic development, reproduction and cell viability.Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice.Gamma tropomyosin gene products are required for embryonic development.Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies.Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling.New aspects of tropomyosin-regulated neuritogenesis revealed by the deletion of Tm5NM1 and 2.Divergent regulation of the sarcomere and the cytoskeleton.Lymphotoxin controls alphaEbeta7-integrin expression by peripheral CD8+ T cells.Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair.Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathyDysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous systemCharacterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow
P50
Q28505295-20EC5C29-D256-4B9D-B27A-3CA8A7E66E93Q28506176-A4D93E51-53A5-49D1-8755-7081E6217739Q28513670-77040A75-C099-4F22-A823-A2097F4FA4B2Q28586439-ABA5AA99-B321-4ABE-9C59-B2F30134489FQ33717569-CDF5E51F-13D3-4BF7-A189-1D4F6FA1DEE8Q34504075-64386D0A-9A27-4C34-B073-A80F46534BCDQ35172293-DAC34E16-7801-44DD-BCA7-1255A729C68AQ36404217-6E572390-1CD1-428E-AD6B-A3CD792BCFC5Q36572071-E86EDBD3-9C6E-408E-8DDF-D60EDB76F1DEQ36812645-32D84106-5D43-4173-8119-9C8DE27AB867Q38075201-15AEE0C3-E7EF-494E-937B-4D315A548174Q38964281-F1C1D55D-AFA8-4686-8959-3BCA51517ABCQ39728841-D514FCAD-CD4B-46CF-A90B-3A12A6726137Q46939319-00E8BCCF-89D5-452A-801D-CB58A69D7D5CQ52543587-A7EB0E64-7D4E-4690-9A91-B293E024943CQ53115389-8DE6372D-3CBE-4A64-8753-E5AE188A533CQ57976181-0A21A456-0E10-4917-8041-28175AF196DEQ64981707-9A9D2C8C-5C5A-48C4-B91A-BB172971BC3FQ73691790-6939F466-6E2A-4219-BF9F-B339C12A0EA6Q80155832-BA2B3A48-5787-420C-ABEF-7FF89EB8356A
P50
description
researcher
@en
name
Frances A. Lemckert
@en
Lemckert FA
@nl
type
label
Frances A. Lemckert
@en
Lemckert FA
@nl
altLabel
Lemckert FA
@en
prefLabel
Frances A. Lemckert
@en
Lemckert FA
@nl
P106
P31
P496
0000-0002-5687-145X